NexGel Inc (NXGL)
2.39
+0.10
(+4.37%)
USD |
NASDAQ |
May 17, 16:00
2.39
0.00 (0.00%)
After-Hours: 20:00
NexGel Cash from Financing (Quarterly): 0.929M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.929M |
| December 31, 2023 | 0.294M |
| September 30, 2023 | 0.088M |
| June 30, 2023 | -0.001M |
| March 31, 2023 | -0.002M |
| December 31, 2022 | -0.15M |
| September 30, 2022 | -1.479M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | -2.033M |
| December 31, 2021 | 13.17M |
| September 30, 2021 | 1.519M |
| Date | Value |
|---|---|
| June 30, 2021 | 0.00 |
| March 31, 2021 | 1.65M |
| December 31, 2020 | 0.458M |
| September 30, 2020 | 0.398M |
| June 30, 2020 | 0.408M |
| March 31, 2020 | 0.62M |
| December 31, 2019 | 0.56M |
| September 30, 2019 | 0.17M |
| June 30, 2019 | 0.789M |
| March 31, 2019 | 0.556M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-2.033M
Minimum
Mar 2022
13.17M
Maximum
Dec 2021
0.8695M
Average
0.346M
Median
Cash from Financing (Quarterly) Benchmarks
| Anika Therapeutics Inc | -2.273M |
| The Cooper Companies Inc | 212.30M |
| Staar Surgical Co | 4.056M |
| OrthoPediatrics Corp | -0.573M |
| Innovative Eyewear Inc | -0.076M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -1.092M |
| Cash from Investing (Quarterly) | -0.118M |
| Free Cash Flow | -4.379M |
| Free Cash Flow Per Share (Quarterly) | -0.208 |
| Free Cash Flow to Equity (Quarterly) | -1.156M |
| Free Cash Flow to Firm (Quarterly) | -1.229M |
| Free Cash Flow Yield | -32.09% |